$0.37
0.72% yesterday
Nasdaq, Sep 03, 10:00 pm CET
ISIN
US00688A1060
Symbol
ADIL

Adial Pharmaceuticals, Inc. Stock price

$0.37
-0.04 9.97% 1M
-0.36 48.84% 6M
-0.64 62.97% YTD
-0.63 62.60% 1Y
-12.32 97.05% 3Y
-32.63 98.87% 5Y
-100.88 99.63% 10Y
-100.88 99.63% 20Y
Nasdaq, Closing price Wed, Sep 03 2025
-0.00 0.72%
ISIN
US00688A1060
Symbol
ADIL
Industry

Key metrics

Basic
Market capitalization
$8.2m
Enterprise Value
$2.2m
Net debt
positive
Cash
$5.9m
Shares outstanding
21.5m
Valuation (TTM | estimate)
P/E
negative | negative
P/S
- | -
EV/Sales
- | -
EV/FCF
negative
P/B
1.5
Financial Health
Equity Ratio
80.7%
Return on Equity
-324.4%
ROCE
-148.5%
ROIC
-
Debt/Equity
0.0
Financials (TTM | estimate)
Revenue
$0.0 | $0.0
EBITDA
$-8.3m | -
EBIT
$-8.3m | $-8.6m
Net Income
$-8.5m | $-19.2m
Free Cash Flow
$-6.5m
Growth (TTM | estimate)
Revenue
- | -
EBITDA
-14.0% | -
EBIT
-14.1% | -4.1%
Net Income
31.0% | -45.6%
Free Cash Flow
-1.4%
Margin (TTM | estimate)
Gross
-
EBITDA
- | -
EBIT
-
Net
- | -
Free Cash Flow
-
More
EPS
$-0.8
FCF per Share
$-0.3
Short interest
8.5%
Employees
5
Rev per Employee
$0.0
Show more

Is Adial Pharmaceuticals, Inc. a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?

As a Free StocksGuide user, you can view scores for all 7,003 stocks worldwide.

Adial Pharmaceuticals, Inc. Stock Analysis

Unlock Scores for Free

Analyst Opinions

9 Analysts have issued a Adial Pharmaceuticals, Inc. forecast:

7x Buy
78%
2x Hold
22%

Analyst Opinions

9 Analysts have issued a Adial Pharmaceuticals, Inc. forecast:

Buy
78%
Hold
22%

Financial data from Adial Pharmaceuticals, Inc.

Income Statement P&L | Balance Sheet | Cash Flow


Quarter TTM Annually
Jun '25
+/-
%
- -
-
100%
- Direct Costs - -
-
-
- -
-
-
- Selling and Administrative Expenses 5.06 5.06
5% 5%
-
- Research and Development Expense 3.24 3.24
67% 67%
-
-8.30 -8.30
14% 14%
-
- Depreciation and Amortization - -
-
-
EBIT (Operating Income) EBIT -8.30 -8.30
14% 14%
-
Net Profit -8.45 -8.45
31% 31%
-

In millions USD.

Don't miss a Thing! We will send you all news about Adial Pharmaceuticals, Inc. directly to your mailbox free of charge.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

Adial Pharmaceuticals, Inc. Stock News

Neutral
GlobeNewsWire
about 18 hours ago
GLEN ALLEN, Va., Sept. 03, 2025 (GLOBE NEWSWIRE) -- Adial Pharmaceuticals, Inc. (NASDAQ: ADIL) (“Adial” or the “Company”), a clinical-stage biopharmaceutical company focused on developing therapies for the treatment and prevention of addiction and related disorders, today announced that it has been granted a 180 calendar day extension from The Nasdaq Stock Market LLC (“Nasdaq”) to regain compli...
Neutral
GlobeNewsWire
21 days ago
GLEN ALLEN, Va., Aug. 14, 2025 (GLOBE NEWSWIRE) -- Adial Pharmaceuticals, Inc. (NASDAQ: ADIL) (“Adial” or the “Company”), a clinical-stage biopharmaceutical company focused on developing therapies for the treatment and prevention of addiction and related disorders, today provided a business update and reported its financial results for the second quarter of 2025.
Neutral
GlobeNewsWire
29 days ago
Meeting Completion Marks Major Step Toward Phase 3 AD04 Trial Launch Strategic Partnership Discussions Expected Following the Positive FDA Meeting GLEN ALLEN, Va., Aug. 06, 2025 (GLOBE NEWSWIRE) -- Adial Pharmaceuticals, Inc. (NASDAQ: ADIL) (“Adial” or the “Company”), a clinical-stage biopharmaceutical company focused on developing therapies for the treatment and prevention of addiction and rel...
More Adial Pharmaceuticals, Inc. News

Company Profile

Adial Pharmaceuticals, Inc. operates as a clinical stage biopharmaceutical company, which focuses on the treatment of alcohol use disorder. Its lead product is AD04, a selective serotonin-3 antagonist. The company was founded by Bankole A. Johnson in November 2010 and is headquartered in Charlottesville, VA.

Head office United States
CEO Cary Claiborne
Employees 5
Founded 2010
Website www.adialpharma.com

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today